115 related articles for article (PubMed ID: 37279073)
1. MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma.
Nirala BK; Patel TD; Kurenbekova L; Shuck R; Dasgupta A; Rainusso N; Coarfa C; Yustein JT
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37279073
[TBL] [Abstract][Full Text] [Related]
2. SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.
Ferrena A; Wang J; Zhang R; Karadal-Ferrena B; Al-Hardan W; Singh S; Borjihan H; Schwartz EL; Zhao H; Oktay MH; Yang R; Geller DS; Hoang BH; Zheng D
Mol Cancer Ther; 2024 Feb; 23(2):223-234. PubMed ID: 37871911
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
Cersosimo F; Lonardi S; Bernardini G; Telfer B; Mandelli GE; Santucci A; Vermi W; Giurisato E
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717819
[TBL] [Abstract][Full Text] [Related]
4. SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis.
Ferrena A; Wang J; Zhang R; Karadal-Ferrena B; Al-Hardan W; Singh S; Borjihan H; Schwartz E; Zhao H; Yang R; Geller D; Hoang B; Zheng D
bioRxiv; 2023 May; ():. PubMed ID: 37214958
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma.
Chim LK; Williams IL; Bashor CJ; Mikos AG
Biomaterials; 2023 May; 296():122076. PubMed ID: 36931102
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment.
Lei Y; Junxin C; Yongcan H; Xiaoguang L; Binsheng Y
J Bone Oncol; 2020 Dec; 25():100322. PubMed ID: 33083216
[TBL] [Abstract][Full Text] [Related]
7. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
Graham MK; Wang R; Chikarmane R; Wodu B; Vaghasia A; Gupta A; Zheng Q; Hicks J; Sysa-Shah P; Pan X; Castagna N; Liu J; Meyers J; Skaist A; Zhang Y; Schuebel K; Simons BW; Bieberich CJ; Nelson WG; Lupold SE; DeWeese TL; De Marzo AM; Yegnasubramanian S
bioRxiv; 2023 Oct; ():. PubMed ID: 37905029
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells suppress the motility of cytotoxic T cells in Friend retrovirus-infected mice.
Mittermüller D; Otto L; Long Z; Kraus A; Beer A; Hasenberg A; Zelinskyy G; Westmeier J; Hasenkrug KJ; Dittmer U; Gunzer M
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427590
[TBL] [Abstract][Full Text] [Related]
9. A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.
Lin WH; Feathers RW; Cooper LM; Lewis-Tuffin LJ; Chen J; Sarkaria JN; Anastasiadis PZ
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427593
[TBL] [Abstract][Full Text] [Related]
10. A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases.
Boyles JS; Sadowski D; Potter S; Vukojicic A; Parker J; Chang WY; Ma YL; Chambers MG; Nelson J; Barmettler B; Smith EM; Kersjes K; Himes ER; Lin C; Lucchesi J; Brahmbhatt J; Sina R; Martin JA; Maestri E; Wiethoff CM; Dyas GL; Linnik MD; Na S; Witcher DR; Budelsky A; Rubtsova K
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427592
[TBL] [Abstract][Full Text] [Related]
11. TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome.
Messerschmidt JL; Azin M; Dempsey KE; Demehri S
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427591
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
Jeong MH; Urquhart G; Lewis C; Chi Z; Jewell JL
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427586
[TBL] [Abstract][Full Text] [Related]
14. ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission.
Semmes EC; Miller IG; Rodgers N; Phan CT; Hurst JH; Walsh KM; Stanton RJ; Pollara J; Permar SR
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427588
[TBL] [Abstract][Full Text] [Related]
15. Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapy.
Osei-Hwedieh DO; Sedlacek AL; Hernandez LM; Yamoah AA; Iyer SG; Weiss KR; Binder RJ
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427594
[TBL] [Abstract][Full Text] [Related]
16. Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.
Cho JH; Kilfoil PJ; Zhang R; Solymani RE; Bresee C; Kang EM; Luther K; Rogers RG; de Couto G; Goldhaber JI; Marbán E; Cingolani E
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427587
[No Abstract] [Full Text] [Related]
17. Advances in Osteosarcoma.
Panez-Toro I; Muñoz-García J; Vargas-Franco JW; Renodon-Cornière A; Heymann MF; Lézot F; Heymann D
Curr Osteoporos Rep; 2023 Aug; 21(4):330-343. PubMed ID: 37329384
[TBL] [Abstract][Full Text] [Related]
18. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract][Full Text] [Related]
19. A cruel invasion of Ewing's sarcoma of the skull: A rare case report.
Zare F; Shahbazi N; Faraji N; Goli R; Mostafaei B; Anari S
Int J Surg Case Rep; 2023 Jul; 108():108380. PubMed ID: 37406533
[TBL] [Abstract][Full Text] [Related]
20. Circulating exosomal microRNAs as biomarkers of lupus nephritis.
Chen F; Shi B; Liu W; Gong J; Gao J; Sun Y; Yang P
Front Immunol; 2023; 14():1326836. PubMed ID: 38223506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
